ABBV registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Completion date | Oct 1, 2026 (actual) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Jul 28, 2025 (actual) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Jul 28, 2025 (actual) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Completed | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Oct 13, 2026 (actual) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Jun 18, 2026 (actual) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Aug 2028 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Aug 2028 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Oct 16, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Oct 16, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Sep 11, 2026 (actual) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Sep 11, 2026 (actual) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Completed | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Oct 1, 2026 (actual)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT07728188A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard...ABBV
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT06937034Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's DiseaseABBV
- Now
- Jul 28, 2025 (actual)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion dateNCT06937034Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's DiseaseABBV
- Now
- Jul 28, 2025 (actual)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT06937034Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's DiseaseABBV
- Now
- Completed
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion dateNCT04514653RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)ABBVRGNX
- Now
- Oct 13, 2026 (actual)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT04567550RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center...ABBVRGNX
- Now
- Jun 18, 2026 (actual)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatusNCT04567550RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center...ABBVRGNX
- Now
- Completed
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatus
- Now
- Recruiting
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETResults postedNCT03850782Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionABBV
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion dateNCT05889182A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate...ABBV
- Now
- Aug 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion dateNCT05889182A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate...ABBV
- Now
- Aug 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion dateNCT07680686Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult ParticipantsABBV
- Now
- Oct 16, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion dateNCT07680686Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult ParticipantsABBV
- Now
- Oct 16, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatusNCT07680686Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult ParticipantsABBV
- Now
- Completed
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT06023030An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to...ABBV
- Now
- Sep 11, 2026 (actual)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion dateNCT06023030An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to...ABBV
- Now
- Sep 11, 2026 (actual)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatusNCT06023030An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to...ABBV
- Now
- Completed
- Before
- Locked
The previous value and the sponsor's record update date are locked on 20 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.